Avidin attachment to red blood cells via a phoshpolipid derivative of biotin provides complement-resistant immunoerythrocytes

This publication has 22 references indexed in Scilit:

• Complement-opsonized IgG antibody/dsDNA immune complexes bind to CR1 clusters on isolated human erythrocytes
  Clinical Immunology and Immunopathology, 1991
• Streptavidin‐induced lysis of homologous biotinylated erythrocytes Evidence against the key role of the avidin charge in complement activation via the alternative pathway
  FEBS Letters, 1991
• Complement-mediated tumor cell damage induced by antibodies against membrane cofactor protein (MCP, CD46).
  The Journal of Experimental Medicine, 1990
• Relationship between the membrane inhibitor of reactive lysis and the erythrocyte phenotypes of paroxysmal nocturnal hemoglobinuria.
  Journal of Clinical Investigation, 1989
• Immunotargeting of erythrocytes-bound streptokinase provides local lysis of a fibrin clot
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1986
• Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.
  The Journal of Experimental Medicine, 1984
• Red blood cell targeting to collagen‐coated surfaces
  FEBS Letters, 1983
• Affinity targeting of membrane vesicles to cell surfaces
  Experimental Cell Research, 1981
• Complement receptor is an inhibitor of the complement cascade.
  The Journal of Experimental Medicine, 1981
• On the mode of liposome-cell interactions. Biotin-conjugated lipids as ultrastructural probes
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1979